A recent study pointed out that a PIN1 inhibitor could downregulate the proliferation of pancreatic cancer cells, reduce collagen deposition, and inhibit the activation and proliferation of tumor-associated fibroblasts (CAFs) in the tumor stromal microenvironment [22]. The gene discussed is PIN1; the disease is neoplasm.